Immunohistochemistry and Mutation Analysis of SDHx Genes in Carotid Paragangliomas
Authors:
- Anastasiya V. SnezhkinaAnastasiya V. Snezhkina
- Dmitry V. KalininDmitry V. Kalinin
- Vladislav S. PavlovVPVladislav S. Pavlov
- Elena N. LukyanovaELElena N. Lukyanova
- Alexander L. GolovyukAGAlexander L. Golovyuk
- Maria S. FedorovaMFMaria S. Fedorova
- Elena A. PudovaElena A. Pudova
- Maria V. SavvateevaMSMaria V. Savvateeva
- Oleg A. StepanovOSOleg A. Stepanov
- Andrey A. PoloznikovAPAndrey A. Poloznikov
- Tatiana B. DemidovaTDTatiana B. Demidova
- Nataliya V. MelnikovaNataliya V. Melnikova
Open Access
- 22 September 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (18) , 6950
Abstract
Carotid paragangliomas (CPGLs) are rare neuroendocrine tumors often associated with mutations in SDHx genes. The immunohistochemistry of succinate dehydrogenase (SDH) subunits has been considered a useful instrument for the prediction of SDHx mutations in paragangliomas/pheochromocytomas. We compared the mutation status of SDHx genes with the immunohistochemical (IHC) staining of SDH subunits in CPGLs. To identify pathogenic/likely pathogenic variants in SDHx genes, exome sequencing data analysis among 42 CPGL patients was performed. IHC staining of SDH subunits was carried out for all CPGLs studied. We encountered SDHx variants in 38% (16/42) of the cases in SDHx genes. IHC showed negative (5/15) or weak diffuse (10/15) SDHB staining in most tumors with variants in any of SDHx (94%, 15/16). In SDHA-mutated CPGL, SDHA expression was completely absent and weak diffuse SDHB staining was detected. Positive immunoreactivity for all SDH subunits was found in one case with a variant in SDHD. Notably, CPGL samples without variants in SDHx also demonstrated negative (2/11) or weak diffuse (9/11) SDHB staining (42%, 11/26). Obtained results indicate that SDH immunohistochemistry does not fully reflect the presence of mutations in the genes; diagnostic effectiveness of this method was 71%. However, given the high sensitivity of SDHB immunohistochemistry, it could be used for initial identifications of patients potentially carrying SDHx mutations for recommendation of genetic testing.Keywords
Funding Information
- Russian Science Foundation (17-75-20105)
- Ministry of Science and Higher Education of the Russian Federation (075-15-2019-1660)
This publication has 66 references indexed in Scilit:
- Kaviar: an accessible system for testing SNV noveltyBioinformatics, 2011
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing dataGenome Research, 2010
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing dataNucleic Acids Research, 2010
- SDHA is a tumor suppressor gene causing paragangliomaHuman Molecular Genetics, 2010
- Fast and accurate long-read alignment with Burrows–Wheeler transformBioinformatics, 2010
- Detection of nonneutral substitution rates on mammalian phylogeniesGenome Research, 2009
- Identification of deleterious mutations within three human genomesGenome Research, 2009
- SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma–paraganglioma syndromesJournal of Internal Medicine, 2009
- The Sequence Alignment/Map format and SAMtoolsBioinformatics, 2009
- Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomesGenome Research, 2005